Skip to main content
. 2021 Aug 16;13(8):1261. doi: 10.3390/pharmaceutics13081261
API Active pharmaceutical ingredient
AUC Area under the plasma (blood) curves
BCS Biopharmaceutics Classification System
BDDCS Biopharmaceutics Drug Disposition Classification System
CAM Complementary alternative medicine
CRASD Controlled release amorphous solid dispersion systems
CYPs Cytochrome P450
Cmax Maximum (peak) drug concentration in the plasma, serum or whole blood
ER Endoplasmic reticulum
F the extent of drug bioavailability
GIT Gastrointestinal tract
HMG-CoA Hydroxyl-methyl-glutaryl coenzyme A
LNS Lipid-based nanosystems
Microfold cells M cells
NP(s) Nanoparticle(s)
NLC Nanostructured lipid carriers
NPs nanoparticles
PK pharmacokinetics
PLN Polymer-lipid hybrid nanoparticles
PXR Pregnane X receptor
SLN Solid lipid nanoparticles
SJW St. John wort
SNEDDS Self-nanoemulsifying drug delivery systems